NCT06926673 2025-07-03Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3GlaxoSmithKlinePhase 2 Completed62 enrolled 36 charts
NCT03308942 2023-10-16Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer ParticipantsTesaro, Inc.Phase 2 Completed53 enrolled 35 charts